| 
							 
							
							
							Publications in the last 5 years: 
							
							
							Names of corresponding authors are bolded and names 
							of my MSc students are underlined.  Names of my 
							undergraduate students are underlined and 
							italicized.  
							
							
							Names of my research assistants and research 
							associate are underlined and marked with asterisk. 
							
							
							
							 2010: 
							
							
							1.     
							
							
							Kim S-E, 
							Gorrell A, Rader S, Lee CH. (2010) 
							Endoribonuclease activity of human APE1 revealed by 
							a real-time fluorometric assay. Anal Biochem 
							
							398: 69-75. 
							
							
							2.     
							
							
							Tell G, 
							
							Wilson DM III, Lee CH. 
							
							(2010) Intrusion of a DNA-repair protein in the 
							RNome world: is this a beginning of a new era?  
							Mol Cell Biol 
							
							30: 366-371. 
							
							
							3.     
							
							
							Li W-M*,
							Barnes T, Lee CH. 
							
							(2010) Endoribonucleases: enzymes gaining spotlight 
							in mRNA metabolism.  FEBS J 
							
							277: 627-641. 
							
							
							4.  
							
							Kim W-C,
							King D, Lee CH. (2010) 
							RNA-cleaving properties of human apurinic/apyrimidinic 
							endonuclease1 (APE1). Int J Biochem Mol Biol 
							1: 12-25. 
							
							
							5.   
							Lee CH. 
							(2010) Reversing agents for ATP-binding cassette 
							drug transporters. Methods Mol Biol 596: 
							325-340. 
							
							
							2009: 
							
							1.    
							Barnes T,
							Kim W-C, Mantha A, Kim S-E, 
							Izumi T, Sankar M, Lee CH.  (2009) 
							Identification of apurinic/apyrimidinic endonuclease 
							APE1 as the endoribonuclease that cleaves c-myc 
							mRNA.  Nucleic Acids Res. 37: 3946-3958. 
							
							2.    
							Kim W-C,
							Lee CH. (2009) The role of mammalian 
							ribonucleases (RNases) in cancer.  Biochim 
							Biophys Acta-Reviews on Cancer 1796: 99-113. 
							
							
							
							2008: 
							
							
							1.     
							
							 Bassett T,
							Harpur B, Kuo HK, Lee CH. 
							(2008) Effective stimulation of growth in MCF-7 
							human breast cancer cells by inhibition of 
							syntaxin18 by external guide sequence and 
							ribonuclease P.  Cancer Letts 
							272:167-175. 
							
							
							
							2007: 
							
							
							1.   
							
							Tafech A,
							Bennett W, Mills F, 
							Lee CH. (2007) Identification of c-myc 
							coding region determinant RNA sequences and 
							structures cleaved by an RNase1-like 
							endoribonuclease.  Biochim Biophys Acta 
							1769: 49-60. 
							
							
							2.   
							
							Sparanese D,
							Lee CH.  (2007) CRD-BP shields c-myc 
							and MDR-1 RNA from endonucleolytic attack by 
							a mammalian endoribonuclease.  Nucleic Acids 
							Res 
							35: 1209-1221. 
							
							
							
							2006: 
							
							
							1.   
							
							Tafech A, 
							Bassett T, Sparanese D, Lee CH.  
							(2006) Destroying RNA as a Therapeutic Approach.  
							Curr Med Chem 13: 863-881. 
							
							
							2.   
							
							Bergstrom K*,
							Urquhart J, Tafech A, Doyle E,
							Lee CH.  (2006) Purification and 
							characterization of a novel mammalian 
							endoribonuclease.  J Cell Biochem 98: 
							519-537. 
							
							
							
							2005: 
							
							
							1.   
							
							
							Lee CH,
							Rehaume V*, Shandro J. (2005) 
							Identification of in vivo P-glycoprotein mRNA 
							decay intermediates in normal liver but not in liver 
							tumors.  J Cell Physiol  204: 
							638-645. 
							
							
							
							2004: 
							
							
							1.   
							
							
							Eberding A,
							Rehaume V*, Lee CH. (2004) Detection 
							of mRNA degradation intermediates in tissues using 3'end 
							poly(A)-tailing polymerase chain reaction method.  
							Anal Biochem 335: 58-65. 
							
							
							2.   
							
							
							Lee CH. 
							(2004) Drug resistance in cancer therapy: Reversing 
							agents for ABC drug transporters. Curr Med Chem 
							 
							Anti-Cancer Agents  
							4: 1-10.  |